Rectal Cancer MRI: Post Treatment Evaluation-- Gaurav Khatri, MD & Katrina McGinty, MD (SABI '19)

Поделиться
HTML-код
  • Опубликовано: 28 июл 2024
  • See the full SCBT-MR/SABI 42nd Annual Course in online streaming format at www.Meetings-By-Mail.com!
    Meetings By Mail presents this lecture from the SCBT-MR/SABI 42nd Annual Course. This presentation is from the Conference's session on Hepatobiliary and Pancreas Imaging.

Комментарии • 8

  • @balaji4057
    @balaji4057 2 года назад

    Split scar post rx

  • @EveryDooDarnDiddlyDay
    @EveryDooDarnDiddlyDay Год назад

    Yeah...they cured this already

    • @Johnny-ip4mk
      @Johnny-ip4mk 8 месяцев назад

      What do you mean?

    • @EveryDooDarnDiddlyDay
      @EveryDooDarnDiddlyDay 8 месяцев назад

      @@Johnny-ip4mk Dostarlimab, monoclonal antibodies, Immunotherapy.

    • @EveryDooDarnDiddlyDay
      @EveryDooDarnDiddlyDay 8 месяцев назад

      @@Johnny-ip4mk ruclips.net/video/YeGjdnoriz4/видео.htmlsi=U-dAjVf4MQ8GsPrz

    • @Johnny-ip4mk
      @Johnny-ip4mk 8 месяцев назад

      @@EveryDooDarnDiddlyDay No surgery?

    • @EveryDooDarnDiddlyDay
      @EveryDooDarnDiddlyDay 8 месяцев назад +1

      @@Johnny-ip4mk Just one pill a week.

  • @rajivkapur78
    @rajivkapur78 3 года назад

    Only TRG needs to be given or we can actually restage from T3 to T2 based on response? Need clarification if in a T3 disease, post treatment all the tumor is T2 hypo suggestive of fibrosis, so should it remain T3 disease with 1/2 TRG or it can be downgraded to T2.